U.S. Wireless Telecom Stock News

Earlier this week, MARA Holdings Inc. came under pressure as a pullback in Bitcoin and broader macroeconomic worries weighed on sentiment toward its bitcoin-focused business model. The reaction highlights how tightly MARA’s outlook is tied to cryptocurrency prices, despite its push to scale mining capacity and retain over 50,000 BTC on its balance sheet. We’ll now examine how this Bitcoin-driven sentiment shift interacts with MARA’s evolving investment narrative, especially its...

In August 2026, Credit Acceptance Corporation completed a US$600.0 million asset-backed non-recourse secured financing, transferring about US$750.2 million of loans into a trust that issued three note classes with average lives between roughly 2.5 and 3.7 years and an expected annualized cost of around 5.5%. The deal allows Credit Acceptance to refinance higher-cost debt while retaining about US$1.80 billions of unused borrowing capacity and preserving dealer holdback arrangements, leaving...

Earlier this month, FMC reported second-quarter 2026 adjusted earnings of US$0.26 per share, surpassing estimates even as results fell very sharply from a year earlier and the company cut its full-year 2026 revenue outlook excluding India. The combination of an earnings beat alongside a weaker revenue guidance and downward-trending analyst estimates has sharpened focus on how resilient FMC’s underlying crop protection business really is. We’ll now examine how FMC’s earnings beat alongside...

OneSpaWorld Holdings Stock Overview OneSpaWorld Holdings (OSW) operates health and wellness centers on cruise ships and at resorts, and its stock has drawn attention after a recent pullback over the past week and month. The company has a market value of about US$2.56b, with reported annual revenue of roughly US$1.01b and net income of about US$81 million. This has put current share performance in the spotlight for investors tracking service-focused consumer stocks. At a recent share price of...

Full Truck Alliance Co. Ltd. has reported its second-quarter 2026 results, with CNY 3,381.57 million in sales, CNY 1,330.03 million in net income, issued third-quarter 2026 revenue guidance of CNY 3.32–3.42 billion compared with CNY 3.36 billion a year earlier, and affirmed a quarterly dividend of US$0.0798 per share payable on October 28, 2026. While first-half 2026 net income of CNY 2,320.93 million and earnings per share were lower than a year earlier, the combination of steady quarterly...

In August 2026, Trane Technologies announced a collaboration with Eaton to introduce an integrated thermal management and electrical system reference design for AI-focused data centers, aiming to improve energy efficiency, cut copper usage, lower installation costs and speed deployment compared with traditional low-voltage setups. A key insight is that this unified “grid-to-chip” architecture aligns Trane’s and Eaton’s platforms with NVIDIA’s DSX ecosystem, positioning them as core...

Hycroft Mining Holding Corporation recently released additional drill results from its 2025-2026 Exploration Drill Program at the Hycroft Mine in Nevada, highlighting high-grade silver and gold intercepts at the Brimstone and Vortex zones and ongoing work to test a potential feeder system at depth. The continuity of mineralization at Brimstone and the extension of high-grade silver at Vortex together point to increased operational flexibility, with grades described by the company as...

It's been a good week for Materialise NV ( NASDAQ:MTLS ) shareholders, because the company has just released its latest...

We note that the Hamilton Beach Brands Holding Company ( NYSE:HBB ) Senior VP, Sally Cunningham, recently sold US$98k...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Even if it's not a huge purchase, we think it was good to see that Gary Evans, the CEO & Chairman of United States...

With central banks signalling ongoing vigilance on inflation, hard assets are back in the spotlight and silver has attracted fresh attention. At the same time, demand from AI hardware, solar panels and electric vehicles is pulling more silver into industrial use. That gap between interest in inflation hedges and constrained mine investment is where opportunity sits. This article highlights three top silver stocks that are positioned for this theme. The stocks covered below are just a starting...

Why Alignment Healthcare Stock Is Back in Focus Alignment Healthcare (ALHC) is under fresh scrutiny after multiple shareholder rights law firms announced investigations into alleged accounting issues flagged by a whistleblower, including claims about misclassified expenses and inflated financial metrics. At a recent share price of US$13.62, Alignment Healthcare has seen short term momentum revive, with a 7 day share price return of 3.5% and a 90 day gain of 2.4%, although the 30 day share...

Fluor recently moved closer to completing Novelis’ approximately US$5.00 billion aluminum recycling plant in Bay Minette, Alabama, where it has been providing engineering, procurement and construction management services, with commissioning expected to begin before the end of 2026. This progress on a large, complex industrial project comes as valuation analyses suggest Fluor’s shares may be trading below estimates of their cash flow–based intrinsic value, potentially reshaping how investors...

Gap Inc. recently reported past second-quarter results showing net sales of US$3,651 million versus US$3,725 million a year earlier, with net income rising to US$501 million from US$216 million, alongside higher full-year earnings guidance and continued share repurchases under its 2026 buyback program. At the same time, Gap and DoorDash expanded on-demand access to Gap and Gap Factory merchandise across much of the U.S., and Gap appointed Michael Francis as incoming Old Navy CEO, moves that...

Conference appearance puts focus on Ligand Pharmaceuticals stock Ligand Pharmaceuticals (LGND) is set to present at the 17th Annual Midwest IDEAS Conference in Chicago on 26 August 2026 at 9:15 a.m., drawing attention to its business model and recent share performance. Recent trading has been slightly softer around the conference, with the share price down 1.42% over the past day and 2.45% over the past month. However, Ligand Pharmaceuticals still shows strong momentum with a 47.54% year to...

NewMarket (NEU) is back on investor radars after recent share price moves and a fresh look at its valuation profile. The stock closed at US$914.69, with an estimated intrinsic discount of 32.5%. Over the past few months NewMarket’s share price has gained momentum, with a 30 day share price return of 7.6% and a 90 day share price return of 14.7%. The 5 year total shareholder return of 193.4% highlights how strongly long term holders have been rewarded. Spot similar momentum stories by scanning...

Why a new class action lawsuit matters for GoDaddy investors GoDaddy (GDDY) is in focus after Kaplan Fox & Kilsheimer LLP filed a securities class action tied to the company’s 2025 promotions and subsequent bookings disclosures. For shareholders, the case raises questions about disclosure practices. Against this backdrop, GoDaddy’s 1 month share price return of 18.08% points to short term momentum building from the recent low base, even though the year to date share price return has declined...

Tempus AI (TEM) shares are drawing attention after the company received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, its AI software for detecting pulmonary hypertension from standard ECGs. The FDA news lands after a volatile stretch for Tempus AI, with the share price down 9.41% over the past day and 11.90% over the past week, yet still posting a 45.98% 30 day share price return and a 21.29% 90 day share price return. The 1 year total shareholder return is...

Earlier this week, Freedom Broker analysts issued a Sell recommendation on LGI Homes after new U.S. tariffs of up to 50% on more than 500 Canadian lumber and building material categories raised concerns about higher construction costs and margin pressure. The analysts warned that, with mortgage rates already constraining demand, LGI Homes may struggle to fully pass these cost increases to buyers, potentially forcing trade-offs between profitability and the pace of new community...

Blue Owl Capital (OWL) is back in focus after funds it manages led a US$2.4b compute equipment financing for IREN Limited, aimed at deploying NVIDIA Blackwell Ultra GPUs for AI Cloud expansion. Against this backdrop, Blue Owl Capital’s recent AI infrastructure financing arrives during a rebound in the stock. The 30 day share price return is 16.7% and the 90 day gain is 14.8%, even though the year to date share price return is down 21.49% and the 1 year total shareholder return is down 29.93%...

C.H. Robinson Worldwide recently reported past second-quarter 2026 results that beat earnings and revenue expectations, driven by stronger pricing and volume across key segments and improved operating profitability. An interesting takeaway is management’s continued confidence in achieving its 2026 adjusted operating income goals despite earlier downward estimate trends, underscoring operational discipline. Now we’ll explore how this earnings outperformance and management’s confidence could...

In August 2026, Guardant Health said it would appeal a US District Court of Delaware final judgment in a patent dispute with TwinStrand Biosciences and the University of Washington, with execution of the judgment and collection of potential royalties paused during the appeal. The court’s royalty order applies mainly to older Guardant tests, while Guardant reports that upgraded versions of key products such as Shield and Reveal, along with validated design changes to Guardant360, fall outside...

Takeda recently announced that the U.S. FDA approved MIMRYLO (rusfertide), a first-in-class hepcidin mimetic peptide, for treating erythrocytosis in adults with polycythemia vera, triggering US$275,000,000 in milestone payments to Protagonist Therapeutics. This approval not only validates Protagonist’s peptide platform but also establishes the first approved hepcidin mimetic therapy in polycythemia vera, potentially reshaping treatment approaches for hematocrit control and phlebotomy...